Description
THIS REPORT:
Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics
Offers a global analysis, with emphasis on U.S. data, and a fiv...(more)
Description
Introduction
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new te...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
REPORT HIGHLIGHTS
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
Key Trends in Drug-Diagnostic Co-Development
Identifying collaborative opportunities and navigating regulatory challenges
Report Overview
The development of genomics-based ...(more)
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
REPORT HIGHTLIGHTS
Description
In BMI’s updated Business Environment Rankings (BER) for Q109, Peru has slipped from second-last tolast position in the Americas matrix, thus remaining one of the least attractive pharmaceutical...(more)
Description
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price product...(more)
Description
Introduction
This databook provides insight into the top 10 companies in Canada life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
The Chinese Hospital Pharmaceutical Market Outlook to 2014’ provides comprehensive coverage of the Chinese pharmaceutical market, reviewing the market structure, pricing and regulation, and incl...(more)
Description
Euromonitor International's Wound Treatments in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-200...(more)
Description
Euromonitor International's Eye Care in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allow...(more)
Description
Smoking is the leading cause of preventable death in the world. The effects of smoking represent a global pandemic of enormous proportions. Currently-marketed smoking cessation aids typically lack hig...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
Introduction
WHO and the European Centre for Disease Prevention and Control (ECDC) are advising countries to prepare
for a more severe second wave of A/H1N1 2009 in the winter of 2009-2...(more)
Description
This quarter BMI introduces 10-year forecasts for the Russian pharmaceutical markets, providing anopportunity to look beyond the current financial crisis and assess the growth potential for the larges...(more)
Description
Introduction
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer ...(more)
Description
Switzerland’s CHF5.9bn (US$5.4bn) drug market has so far avoided the worst effects of the globalfinancial crisis, growing by around 4% in Swiss francs in 2008, However, the next five years are l...(more)
Description
DNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease. The U.S. market for DNA-based infectious disease tests is today a $1.1 billion indus...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
